Endocrine Abstracts

Objective: The goal in this study was to evaluate serum parathormone (PTH) and 25-hydroxy-vitamin D (25OHD), calcium levels and bone mineral density (BMD) in patients with obesity and determine the relationship between biochemical bone parameters, body mass index (BMI) and trabecular/cortical BMD over a wide range of body weights.Methods: We examined 337 women (mean age 41.35 years old; BMI 45.47 kg/m2) who were classified into three categorie...

Objective: There has been no consensus on the medical management of diabetes in acromegaly patients. The primary approach is like the general population, and metformin is considered first-line therapy. Sodium-glucose cotransporter inhibitors (SGLT2is) are a novel antidiabetic class which has an improving effect on insulin resistance. There is no recommendation regarding their use for diabetic acromegaly patients despite their potential beneficial effects by inducing glucosuria...

Congenital adrenal hyperplasia (CAH) refers to an autosomal recessive condition due to 21 hydroxylase (21OHD) deficiency, is characterized by impaired biosynthesis of glucocorticoid and mineralocorticoid. The consequent increase in the ACTH leads to bilateral adrenocortical hyperplasia and hyperandrogenism. Nonclassic CAH (NCCAH) manifests with a less severe clinic that presents later in life with the sympthoms of excessive androgen production. Clinical features include premat...

Introduction: Acromegalic osteopathy is an emerging complication characterized by high risk for vertebral fractures (VFS), whereas bone mineral density (BMD) may not be useful to predict the risk. Recent studies have reported that increased advenced glycation end products (AGEs) are associated with bone fragility. We aimed to evaluate the relationship between AGEs and VFs in patients with acromegaly.Study design: Cross-sectionalPat...

Objective: Increasing obesity rates are causing a surge in non-alcoholic fatty liver disease (NAFLD) prevalence which may progress further to non-alcoholic steatohepatitis (NASH) to cirrhosis. The utility of Fibroscan was shown in stratifying risk for significant liver disease in patients with obesity but it has a limited availability. The aim of the study was to compare the accuracy of Fibrosis-4 (FIB-4)) score to diagnose advanced fibrosis in overweight and obesity patients....

Objective: Higher obesity rates are related with increased non-alcoholic fatty liver disease (NAFLD) prevalence which may progress further to non-alcoholic steatohepatitis (NASH) and cirrhosis. The utility of Fibroscan was shown in stratifying risk for significant liver disease. The aim of the study was to evaluate the relation between body mass index (BMI) and liver stiffness measurements (LSM) in overweight and obese patients.Methods: We conducted the ...